Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients

Leukemia Research

Volumn 24, Issue 12, 2000, Pages 983-992

  Germing, Ulrich ^a   Gattermann, Norbert ^a   Strupp, Corinna ^a   Aivado, Manuel ^a   Aul, Carlo ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chronic myelomonocytic leukemia; FAB classification; Myelodysplastic syndromes; Prognosis; Risk of acute leukemia; WHO classification

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CELL STRUCTURE; CHROMOSOME 5Q; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 0033757263     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00088-6     Document Type: Article

References (34)

1. Proposals for the classification of the myelodysplastic syndromes
2. Utility of the FAB classification for myelodysplastic syndromes: Investigation of prognostic factors in 237 cases
3. A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria
4. Myelodysplastic syndromes: A scoring system with prognostic significance
5. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients
6. Primary myelodysplastic syndromes (MDS): Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
7. Risk assessment in primary myelodysplastic syndromes: Validation of the Dusseldorf score
8. Prognostic factors of myelodysplastic syndromes - A simplified 3-D scoring system
9. Clinical characteristics of japanese patients with primary myelodysplastic syndromes: A cooperative study based on 838 cases
10. Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases
11. International scoring system for evaluating prognosis in myelodysplastic syndromes
12. The chronic myeloid leukemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia
13. Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome?
14. Chronic myelomonocytic leukaemia: Single entity or heterogeneous disorder? A prospective multicenter study of 100 patients
15. Problems in the classification of CMML-dysplastic versus proliferative type
16. The contribution of Auer rods to the classification and prognosis of myelodysplastic syndromes
17. RAEB-T: A heterogenous entity?
18. Two types of acquired idiopathic sideroblastic anaemia (AISA)
19. Heterogeneity of acquired idiopathic sideroblastic anemia (AISA)
20. Two types of acquired idiopathic sideroblastic anaemia: A time-tested distinction
21. Hypocellular myelodysplastic syndromes (MDS): New proposals
22. Unclassifiable myelodysplastic syndrome: A study of sixteen cases with a proposal for a new subtype
23. Refractory cytopenia with multilineage dysplasia: Further characterization of an 'unclassifiable' myelodysplastic syndrome
24. Refractory anemia with severe dysplasia: Clinical significance of morphological features in refractory anemia
25. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues
26. The World Health Organization (WHO) classification of acute leukemias and the myelodysplastic syndromes
27. Nonparametric estimation from incomplete observations
28. Regression models and life-tables
29. The myelodysplastic syndromes
30. Does WBC really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients
31. Clinical implication of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: A multicentric study in Japan
32. Morphological comparison of dysplastic changes between ne novo acute leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes
33. New system for assessing the prognosis of refractory anemia patients
34. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micromegakaryocytes in myelodysplastic syndromes